VIGL
Companies
NASDAQ
Vigil Neuroscience Inc.
Health Care
$7.92
+$6.22 (+365.88%)
Price Chart
Overview
About VIGL
vigil neuroscience is the world’s first microglia-focused therapeutics company. our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. we are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.
Market Cap
$172.9M
Volume
1.2M
Avg. Volume
1.3M
P/E Ratio
-0.8461538
Dividend Yield
0.00%
Employees
57.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.58
Low Correlation
Volatility
High (0.95)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, VIGL shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025